Atossa Genetics (ATOS) Misses Q2 EPS by 1c

Atossa Genetics (NASDAQ: ATOS) reported Q2 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Atossa Genetics (ATOS) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Axis Capital Limited Upgrades Tata Consultancy Services Ltd. (TCS:IN) to Buy (1)
• Berenberg Starts Lloyds Banking Group Plc. (LLOY:LN) (LYG) at Hold